Drug Database
Back to search

Switzerland· 69573002

Metoflex 750 mg, comprimés pelliculés

A methocarbamol product containing methocarbamolum, registered in Switzerland by Labatec Pharma SA and dispensed under Swissmedic category B. The same ATC class is registered in 12 of our 19 countries.

Cat B (Swissmedic)ATC M03BA03

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedMetoflex 750 mg, comprimés pelliculésATCM03BA03REGISTER NO.69573002PACKS LISTED0CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about methocarbamolumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Methocarbamol is registered in 12 of 19 countries.

Countries holding a registration under ATC M03BA03 (methocarbamol), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 7 of them publish a price we can compare per daily dose
Search methocarbamol products by name

Methocarbamol · ATC M03BA03

12 / 19 countries

  • Canada
  • Czechiaprice
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Japan
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of methocarbamol costs, country by country.

Normalised to the WHO defined daily dose (3 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Methocarbamol · price per daily dose (3 g)

USD · FX 28 Sept 2026

  • US United States$0.17 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

Swissmedic (Switzerland)
Active substance
methocarbamolum
Manufacturer
Labatec Pharma SA
Country
Switzerland (CH)
ATC code
M03BA03
ATC class
Methocarbamol
Defined daily dose
3 g, O
Swissmedic category
B
Reimbursed
No
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

169 interactions on record for methocarbamol.

Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check methocarbamol against other medicinesHow interaction checks work

Methocarbamol · interactions on record

169 records

  • 4 severe
  • 53 moderate
  • 112 info

Most severe, free to view

  • MorphineN02AA01severe
  • MorphinN07BC09severe
  • HydrocodoneR05DA03severe
  • CodeineR05DA04severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Methocarbamol in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All methocarbamol products

Authorised across Europe · EMA

The same active substance is authorised in 12 EEA countries. Names it is sold under:

  • Austria · Methocarbamol Kwizda
  • Czechia · Dolirobax
  • Germany · Methoca, Methocarbamol Al
  • Spain · Dolirobax, Molitrem
  • France · Lumirelax, Methocarbamol Arrow
  • United Kingdom (Northern Ireland) · Methocarbamol Activase Pharmaceuticals, Methocarbamol Amarox
  • Hungary · Dolirobax Tabletta
  • Luxembourg · Methocarbamol Micro Labs
  • Malta · Rolaxifor
  • Poland · Methocarbamol Espefa
  • Portugal · Robaxisal, Zelaz
  • Slovakia · Dolirobax

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ee8c156c-837e-4a22-b60e-78abe357f1a3
GET /v1/drugs/ee8c156c-837e-4a22-b60e-78abe357f1a3?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{}
API referenceMCP serverPlans

See everything about methocarbamol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console